Tatiana Jofra
Overview
Explore the profile of Tatiana Jofra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S, et al.
Commun Biol
. 2025 Feb;
8(1):295.
PMID: 39988700
No abstract available.
2.
Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S, et al.
Commun Biol
. 2025 Jan;
8(1):99.
PMID: 39838096
Tregs for adoptive therapy are traditionally expanded ex vivo using high doses of IL-2. However, the final Treg product has limited survival once infused in patients, potentially affecting therapeutic effectiveness....
3.
Cosorich I, Filoni J, Di Dedda C, Ferrari A, Jofra T, Cesarano S, et al.
Immunology
. 2023 Sep;
170(4):540-552.
PMID: 37671510
Adoptive regulatory T-cell (Treg) transfer has emerged as a promising therapeutic strategy for regulating immune responses in organ transplantation, graft versus host disease, and autoimmunity, including Type 1 diabetes. Traditionally,...
4.
Carrera P, Marzinotto I, Bonfanti R, Massimino L, Calzavara S, Favellato M, et al.
Diabetologia
. 2023 Jan;
66(4):695-708.
PMID: 36692510
Aims/hypothesis: Islet autoantibodies (AAbs) are detected in >90% of individuals with clinically suspected type 1 diabetes at disease onset. A single AAb, sometimes at low titre, is often detected in...
5.
Barzaghi F, Cicalese M, Zoccolillo M, Brigida I, Barcella M, Merelli I, et al.
Front Immunol
. 2022 Oct;
13:910021.
PMID: 36248833
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, including vasculitis, immunodeficiency, and hematologic manifestations, potentially progressing over time. The present...
6.
Lorenzo B, Pacillo L, Milardi G, Jofra T, Cesare S, Gerosa J, et al.
Front Immunol
. 2022 Sep;
13:952715.
PMID: 36090979
The immunological events leading to type 1 diabetes (T1D) are complex and heterogeneous, underscoring the necessity to study rare cases to improve our understanding. Here, we report the case of...
7.
Milardi G, Lorenzo B, Gerosa J, Barzaghi F, Di Matteo G, Omrani M, et al.
Eur J Immunol
. 2022 May;
52(7):1171-1189.
PMID: 35562849
Common variable immunodeficiency (CVID) is the most frequent primary antibody deficiency whereby follicular helper T (Tfh) cells fail to establish productive responses with B cells in germinal centers. Here, we...
8.
Vecchione A, Jofra T, Gerosa J, Shankwitz K, Di Fonte R, Galvani G, et al.
Diabetes
. 2021 Oct;
70(12):2892-2902.
PMID: 34620616
In the attempt to understand the origin of autoantibody (AAb) production in patients with and at risk for type 1 diabetes (T1D), multiple studies have analyzed and reported alterations in...
9.
Jofra T, Galvani G, Georgia F, Silvia G, Gagliani N, Battaglia M
Bio Protoc
. 2021 Jun;
8(5):e2743.
PMID: 34179271
Type 1 diabetes (T1D) is an autoimmune disease caused by the lack of insulin-producing pancreatic beta cells leading to systemic hyperglycemia. Pancreatic islet transplantation is a valid therapeutic approach to...
10.
Mancuso G, Jofra T, Lanzillotta M, Aiuti A, Cicalese M, Di Colo G, et al.
Rheumatology (Oxford)
. 2021 Apr;
60(8):3947-3949.
PMID: 33856429
No abstract available.